In order to further promote the supervision of drug production in Fengxian District, the 2018 Fengxian District Drug Production Supervision Work Conference was held on the morning of March 9, 2018.
The leaders of Shanghai Food and Drug Administration's Drug Supervision Office and Fengxian District Market Supervision Administration attended the meeting. The leaders of Fengxian District's drug production enterprises and quality leaders also attended the meeting.
This meeting analyzes and deploys the 2017 regulatory reports on pharmaceutical manufacturers in the district and the key points of regulatory work in 2018.
Jinshan Pharmaceutical will resolutely implement the spirit of the meeting, continue to strengthen quality management, fully implement the corporate responsibility, and ensure the quality of the drug's entire life cycle.